# Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi Deficiency

> **NCT07698574** · NA · NOT_YET_RECRUITING · sponsor: **Beijing University of Chinese Medicine** · enrollment: 240 (estimated)

## Conditions studied

- HIV-1 Infection
- Acquired Immunodeficiency Syndrome
- Immune Reconstitution Failure
- Immunological Non-responder
- Lung-Spleen Qi Deficiency Syndrome

## Interventions

- **DRUG:** Qiling Yiqi Tablets plus ART
- **DRUG:** Antiretroviral Therapy (ART)

## Key facts

- **NCT ID:** NCT07698574
- **Lead sponsor:** Beijing University of Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2028-02
- **Final completion:** 2029-02
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698574, "Qiling Yiqi Tablets Plus Antiretroviral Therapy for HIV Immune Non-responders With Lung-Spleen Qi Deficiency". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07698574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*